Eva Lucille Feldman

Top grants by award amount

Eva Lucille Feldman's NIH grant portfolio, ranked by award amount.

• 5R01NS127188-04R01

  Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort

  University of Michigan
  $719K

  award amount
• 5R01ES030049-05R01

  Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis

  University of Michigan
  $653.1K

  award amount
• 5R01DK130913-03R01

  Metabolic coupling between Schwann cells and axons is functionally distinct from myelination and is disrupted in obesity, prediabetes, and diabetes

  University of Michigan
  $606K

  award amount
• 5R01TS000344-02R01

  RFA-TS-23-001: Establishing the Cohort for Occupational Risk and Prevention Studies for Amyotrophic Lateral Sclerosis (ALS CORPS)

  University of Michigan
  $500K

  award amount
• 5R01DK129320-04R01

  Identifying lifelong factors that impact brain health and outcomes in type 1 diabetes: The Cognition and Longitudinal Assessments of Risk Factors over 30 Years (CLARiFY) Diabetes Complications Study

  University of Michigan
  $439.7K

  award amount

Affiliation

Institutions that have administered grants for Eva Lucille Feldman.

Affiliated with University of Michigan (MI).

Career milestones

Key NIH funding milestones over time.

1. 2024
   First NIH Award
   University of Michigan
2. 2024
   $500K Cumulative Funding
3. 2024
   $1M Cumulative Funding
4. 2024
   $2M Cumulative Funding
5. 2024
   Entered Top 50% Nationally
   Ranked #2758
6. 2024
   Entered Top 25% Nationally
   Ranked #2758

Related investigators

Other NIH-funded PIs frequently associated with Eva Lucille Feldman.